α-Mangostin exhibits antidepressant-like effects mediated by the modification of GABAergic, serotonergic and dopaminergic systems

Nat Prod Res. 2020 Mar;34(6):868-871. doi: 10.1080/14786419.2018.1503659. Epub 2018 Nov 10.

Abstract

The present study explored the antidepressant-like activity of α-mangostin (α-MG) and the possible mechanism in this process in the tail suspension test (TST) in mice. The results revealed that α-MG (5 mg/kg, i.p.) exhibited markedly antidepressant-like activity, which could be reversed by pretreatment with haloperidol (a non-selective D2 receptor antagonist), bicuculline (a competitive GABA antagonist), p-chlorophenylalanine (an inhibitor of 5-HT synthesis). Meanwhile, α-MG also effectively increased the brain DA, 5-HT and GABA levels in mice exposed to TST, indicating that the antidepressant-like effect of α-MG might be mediated by the GABAergic, serotonergic and dopaminergic systems.[Formula: see text].

Keywords: GABAergic; antidepressant-like effect; dopaminergic; serotonergic; tail suspension test; α-mangostin.

MeSH terms

  • Animals
  • Antidepressive Agents / chemistry
  • Antidepressive Agents / isolation & purification*
  • Antidepressive Agents / pharmacology
  • Brain / drug effects
  • Brain / metabolism
  • Depression / drug therapy
  • Dopamine / metabolism*
  • Mice
  • Serotonin / metabolism*
  • Xanthones / pharmacology*
  • Xanthones / therapeutic use
  • gamma-Aminobutyric Acid / metabolism*

Substances

  • Antidepressive Agents
  • Xanthones
  • Serotonin
  • gamma-Aminobutyric Acid
  • mangostin
  • Dopamine